Adamas Pharmaceuticals
ADMS
#7204
Rank
C$0.52 B
Marketcap
$11.39
Share price
0.00%
Change (1 day)
16,574.72%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -C$48.83 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are C$88.18 Million. In 2020 the company made an earning of -C$60.77 Million, an increase over its 2019 earnings that were of -C$0.13 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$48.83 Million-19.65%
2020-C$60.77 Million-51.34%
2019-C$0.13 Billion-19.45%
2018-C$0.16 Billion28.96%
2017-C$0.13 Billion42.3%
2016-C$84.49 Million6.18%
2015-C$79.57 Million-410.24%
2014C$25.64 M-67.53%
2013C$78.98 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.3 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.14 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.08 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$29.37 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA